Trial | NCT01723241  Report issue

Title

Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers
A Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose Study to Assess the Safety and Tolerability of XAF5 Gel Applied to the Skin of Healthy Volunteers

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    xoph5 ...

  • Study Participants

    32
This is a study to assess the safety, tolerability, and pharmacokinetics of XAF5 Gel when applied to the skin of healthy volunteers.
Study Started
Nov 30
2012
Primary Completion
Apr 30
2013
Study Completion
Apr 30
2013
Last Update
Jan 12
2016
Estimate

Drug XAF5, concentration A

Drug XAF5, concentration B

Drug XAF5, concentration C

Drug Placebo

XAF5 Experimental

Placebo Placebo Comparator

Criteria 

Inclusion Criteria:

Healthy volunteers
Must understand and provide informed consent
Skin upon which a reaction would be visible
Body weight >= 70 kg

Exclusion Criteria:

Any active skin disease
History of skin hypersensitivity
Clinically significant abnormality on physical exam, ECG, or laboratory tests
Positive test for HIV, Hepatitis B, or Hepatitis C
No Results Posted